Bard Brachytherapy, Inc.
Bard Brachytherapy, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-1702-2018, Class II) was initiated on April 10, 2018.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 3
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-1702-2018 | Class II | BARD¿ BrachySource¿ Iodine125 radioactive seeds consist of a welded titanium capsule containing the | April 10, 2018 |